NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aseptuva AG

Aseptuva AG

Private
BernHealthcare & Life Scienceshttps://www.aseptuva.com/

Last Round

Grant

May 30, 2025

Total Funding Raised

$2.29M

Company Overview

Aseptuva AG is a medical technology company that develops automated Far-UVC disinfection adaptors for catheters to prevent hospital-acquired infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

infection preventionmedical devicehealthcare-associated infectionsHAIautomated disinfectionFar-UVCcatheter disinfectionhospital hygienemedtechclinical workflowsterilization technologyinfection controlmedical hardwareUV disinfectionpatient safety

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aseptuva AG Comps

Public and private peers based on sector, stage, and business model.

Aseptuva AG comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aseptuva AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 30, 2025
GrantNov 3, 2023
SeedNov 3, 2023
Pre SeedAug 30, 2022
GrantJul 1, 2020

Key People

Founding team and executive leadership

Henry Twerenbold

Co-Founder & CEO

Founding Team

Aseptuva AG Investors

Notable investors and investment history

Aseptuva AG investors
InvestorRounds
Fortyone AGPre Seed, Seed
ValueMaker AGPre Seed, Seed
InnosuisseGrant
Venture KickGrant

Aseptuva AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aseptuva AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aseptuva AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBern
Employee Range11
Year Founded2021
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.